CABA (STOCKS)
Cabaletta Bio, Inc. Common Stock
$2.730000
-0.120000 (-4.21%)
Prev close: $2.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven Nichtberger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $469.02M
- Employees
- 167
- P/E (TTM)
- -1.37
- P/B (TTM)
- 3.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $179.40M |
| Research and Development | $151.01M |
| Other Operating Expenses | $28.39M |
| Operating Income/Loss | -$179.40M |
| Income/Loss From Continuing Operations After Tax | -$175.43M |
| Income/Loss From Continuing Operations Before Tax | -$175.43M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $2.35M |
| Net Income/Loss | -$175.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$175.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$175.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.91 |
| Diluted Earnings Per Share | -$1.91 |
| Assets | $148.15M |
| Current Assets | $122.32M |
| Cash | $116.64M |
| Other Current Assets | $5.68M |
| Noncurrent Assets | $25.83M |
| Fixed Assets | $1.59M |
| Other Non-current Assets | $24.25M |
| Liabilities | $44.84M |
| Current Liabilities | $41.51M |
| Accounts Payable | $6.38M |
| Wages | $3.64M |
| Other Current Liabilities | $31.49M |
| Noncurrent Liabilities | $3.33M |
| Equity | $103.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $103.31M |
| Liabilities And Equity | $148.15M |
| Net Cash Flow From Operating Activities | -$142.84M |
| Net Cash Flow From Operating Activities, Continuing | -$142.84M |
| Net Cash Flow From Investing Activities | $1.48M |
| Net Cash Flow From Investing Activities, Continuing | $1.48M |
| Net Cash Flow From Financing Activities | $126.17M |
| Net Cash Flow From Financing Activities, Continuing | $126.17M |
| Exchange Gains/Losses | -$1.00K |
| Net Cash Flow | -$15.20M |
| Net Cash Flow, Continuing | -$15.19M |
| Comprehensive Income/Loss | -$175.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$175.43M |
| Other Comprehensive Income/Loss | -$44.87M |